NCT05065866 2025-12-04Duvelisib in Combination With BMS-986345 in Lymphoid MalignancyH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed14 enrolled
NCT01871675 2016-07-11Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesSCRI Development Innovations, LLCPhase 1 Completed48 enrolled